Skip to main content
placeholder image

Ethical rationing: Hydroxychloroquine, COVID-19 and the inequality of diseases

Journal Article


Abstract


  • The controversy surrounding the off-label use of hydroxychloroquine (HCQ) for COVID-19 highlights the inherent inequality of disease conditions. In this brief ethics explainer, we argue that we need to make explicit the clinical and non-clinical factors that determine the inequality of diseases. The varying appraisals of disease inequality, in turn, reveal the values that govern the contrasting prioritisation among health care institutions.

Publication Date


  • 2020

Citation


  • Aquino, Y. & Cabrera, N. (2020). Ethical rationing: Hydroxychloroquine, COVID-19 and the inequality of diseases. Journal of Medical Ethics Blog, April 3 1.

Start Page


  • 1

Volume


  • April 3

Place Of Publication


  • United Kingdom

Abstract


  • The controversy surrounding the off-label use of hydroxychloroquine (HCQ) for COVID-19 highlights the inherent inequality of disease conditions. In this brief ethics explainer, we argue that we need to make explicit the clinical and non-clinical factors that determine the inequality of diseases. The varying appraisals of disease inequality, in turn, reveal the values that govern the contrasting prioritisation among health care institutions.

Publication Date


  • 2020

Citation


  • Aquino, Y. & Cabrera, N. (2020). Ethical rationing: Hydroxychloroquine, COVID-19 and the inequality of diseases. Journal of Medical Ethics Blog, April 3 1.

Start Page


  • 1

Volume


  • April 3

Place Of Publication


  • United Kingdom